AstraZeneca’s COVID-19 vaccine trial in the United States is expected to resume as early as this week after the US Food and Drug Administration completed its review of a serious illness, four sources told Reuters.
US trial of AstraZeneca COVID-19 vaccine may resume this week: Report
